NCT06303167
Clinical Trial Information
Trial Number: NCT06303167 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Lymphoma - Miscellaneous
- Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"MATCH Treatment Subprotocol E: Osimertinib (AZD9291) in Patients With Tumors Having EGFR T790M Mutations or Rare Activating Mutations of EGFR"
Study ID:
EAY131-E
Images are available?:
No
Is this a NCI-MATCH Trial?:
Yes
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®